tiprankstipranks
pc:everz

EVerZom

EVerZom is a French biotechnology company specializing in the development of exosome-based therapies for regenerative medicine. The company is advancing a proprietary bioproduction platform that leverages mesenchymal stem cell-derived exosomes, aiming to address high unmet medical needs across multiple therapeutic areas, including inflammatory diseases, hepatology, and dermatology. EVerZom's flagship product, EVerGel™, is set to enter clinical trials for Crohn's disease-related perianal fistulas, showcasing the potential of exosomes as a novel therapeutic modality.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$10M
Latest Funding Amount$10M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 14, 2025
Investment
$10.00M

Investors

Related News and Analysis